Literature DB >> 25825380

The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.

Xiaofang Li1, Qing Cai2, Huan Mei1, Xiaowei Zhou1, Yongnian Shen1, Dongmei Li3, Weida Liu4.   

Abstract

OBJECTIVES: The histone deacetylase (HDAC) has recently been linked to the morphogenesis and virulence of yeast. However, the effects of HDAC on antifungal susceptibility are not well understood. We sought to characterize the action of histone deacetylation on azole resistance in Candida albicans and its possible mechanism of action.
METHODS: A total of 40 C. albicans strains were studied. Azole susceptibility with or without trichostatin A (TSA) was determined according to the CLSI microdilution method. The null mutants of HDA1 and RPD3 (genes targeted by TSA) were also investigated using drop-plate assays and a rapid acquisition of adaptation to the azole test. Transcriptional levels of HDAC genes and efflux genes were quantified using RT-PCR for both the basal and fluconazole-induced conditions.
RESULTS: The inhibition of HDACs by TSA (0.25 mg/L) markedly reduced the trailing growth and the growth of most C. albicans strains. Trailing growth for C. albicans strains was decreased from 2-fold to 256-fold at 48 h. The deletion of HDA1 or RPD3 increased the susceptibility to azoles compared with the WT strain. The expression of HDA1 and RPD3 was up-regulated to different levels, and returned to the level of the susceptible parental strain when stable resistance had formed during the course of acquired fluconazole resistance both in vitro and in vivo. Efflux genes were poorly expressed in mutant strains compared with those of the WT strain.
CONCLUSIONS: Our results indicate the important role of the Rpd3/Hda1 family in the development of azole resistance in C. albicans. Histone deacetylation may govern the expression of genes related to the early stages of adaptation to azole stress, such as efflux pump genes.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  C. albicans; histone deacetylase inhibitors; histone deacetylation; trichostatin A

Mesh:

Substances:

Year:  2015        PMID: 25825380     DOI: 10.1093/jac/dkv070

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.

Authors:  Cécile Garnaud; Encar García-Oliver; Yan Wang; Danièle Maubon; Sébastien Bailly; Quentin Despinasse; Morgane Champleboux; Jérôme Govin; Muriel Cornet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Histone deacetylases: Targets for antifungal drug development.

Authors:  Livia Kmetzsch
Journal:  Virulence       Date:  2015-07-07       Impact factor: 5.882

Review 3.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

Review 4.  Histone deacetylase-mediated morphological transition in Candida albicans.

Authors:  Jueun Kim; Ji-Eun Lee; Jung-Shin Lee
Journal:  J Microbiol       Date:  2015-12-02       Impact factor: 3.422

5.  Extensive functional redundancy in the regulation of Candida albicans drug resistance and morphogenesis by lysine deacetylases Hos2, Hda1, Rpd3 and Rpd31.

Authors:  Xinliu Li; Nicole Robbins; Teresa R O'Meara; Leah E Cowen
Journal:  Mol Microbiol       Date:  2016-12-14       Impact factor: 3.501

6.  The Set1 Histone H3K4 Methyltransferase Contributes to Azole Susceptibility in a Species-Specific Manner by Differentially Altering the Expression of Drug Efflux Pumps and the Ergosterol Gene Pathway.

Authors:  Kortany M Baker; Smriti Hoda; Debasmita Saha; Justin B Gregor; Livia Georgescu; Nina D Serratore; Yueping Zhang; Lizhi Cheng; Nadia A Lanman; Scott D Briggs
Journal:  Antimicrob Agents Chemother       Date:  2022-04-26       Impact factor: 5.938

Review 7.  Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?

Authors:  Karl Kuchler; Sabrina Jenull; Raju Shivarathri; Neeraj Chauhan
Journal:  PLoS Pathog       Date:  2016-11-10       Impact factor: 6.823

8.  Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance.

Authors:  Ulrike Binder; Maria Aigner; Brigitte Risslegger; Caroline Hörtnagl; Cornelia Lass-Flörl; Michaela Lackner
Journal:  J Fungi (Basel)       Date:  2019-09-04

9.  Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice.

Authors:  Xiaohua Li; Min Yuan; Ruijie Yin; Xiaohui Liu; Yu Zhang; Shengtao Sun; Lei Han; Shikun He
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

Review 10.  Histone Deacetylases and Their Inhibition in Candida Species.

Authors:  Cécile Garnaud; Morgane Champleboux; Danièle Maubon; Muriel Cornet; Jérôme Govin
Journal:  Front Microbiol       Date:  2016-08-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.